Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
Cancer Investigation|April 25, 2007
Clinical evaluation of the use of exemestane as further hormonal therapy after nonsteroidal aromatase inhibitors in postmenopausal metastatic breast cancer patientsPaolo Carlini, Andrea Michelotti, Gianluigi Ferretti, et al.
Medical Oncology (Northwood, London, England)|August 3, 2021
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?Riccardo Ray Colciago, Anna Cavallo, Maria Chiara Magri, et al.
Cancers|June 2, 2021
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast CancerCarolina Reduzzi, Serena Di Cosimo, Lorenzo Gerratana, et al.
Frontiers in Oncology|September 29, 2025
Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept studyValentina Appierto, Elena Tamborini, Paola Tiberio, et al.
JAMA Oncology|June 15, 2018
Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical TrialRyan L Powles, David Redmond, Christos Sotiriou, et al.
Cancer Research|October 3, 2008
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutationsVioleta Serra, Ben Markman, Maurizio Scaltriti, et al.
Therapeutic Advances in Medical Oncology|December 20, 2019
An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)Emanuela Risi, Chiara Biagioni, Matteo Benelli, et al.
Scientific Reports|January 31, 2024
A gene expression-based classifier for HER2-low breast cancerSerena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, et al.
Breast (Edinburgh, Scotland)|February 6, 2026
Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysisChiara Dauccia, Marco Bruzzone, Luca Arecco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 5, 2021
Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 TrialSamuel Martel, Matteo Lambertini, Dominique Agbor-Tarh, et al.
Pageof 16